Kyntra Bio reports Q2 2026 results, reaffirms fourth-quarter trial milestonesAug 13Quarterly updateFG-3246Kyntra Bio
Kyntra Bio registers Phase 3 roxadustat trial for anemia in lower-risk MDSJul 23Trial updateKyntra Bioroxadustat
Sign inSign in